OP0189 Tumor necrosis factor inhibitor treatment reduces spinal radiographic progression in ankylosing spondylitis by decreasing disease activity: a longitudinal analysis in a large prospective cohort

Robert Landewé ,Pascal Zufferey ,Almut Scherer ,Jürg Bernhard ,R Kissling ,X Baraliakos ,Ulrich Weber ,G Tamborrini ,Lukas Wildi ,A Ciurea ,Csaba Molnár ,M De Hooge ,Pascale Exer ,Raphael Micheroli ,D Van Der Heijde ,Mary Jo Nissen

doi:10.1136/annrheumdis-2017-eular.2571

OP0189 Tumor necrosis factor inhibitor treatment reduces spinal radiographic progression in ankylosing spondylitis by decreasing disease activity: a longitudinal analysis in a large prospective cohort

Robert Landewé , Pascal Zufferey + Show 14 more

Open Access

https://doi.org/10.1136/annrheumdis-2017-eular.2571

Copy DOI

Journal: Annals of the Rheumatic Diseases

Publication Date: Jun 1, 2017

Affiliation: Hôpital Orthopédique de la Suisse Romande, SCQM Foundation, Solothurner Spitäler, Universitätsklinik Balgrist, Rheumazentrum Ruhrgebiet, Region of Southern Denmark

#Ankylosing Spondylitis Disease Activity Score #Ankylosing Spondylitis + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

BackgroundWhether tumor necrosis factor inhibitors (TNFi) have an influence on radiographic progression in ankylosing spondylitis (AS) remains controversial.ObjectivesTo investigate the impact of TNFi use on spinal radiographic progression in AS.MethodsPatients...

Full Text